X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1312) 1312
male (859) 859
nk1 receptor (776) 776
substance p (744) 744
pharmacology & pharmacy (718) 718
humans (675) 675
index medicus (649) 649
neurosciences (616) 616
substance-p (593) 593
rats (570) 570
neurokinin-1 receptor antagonists (528) 528
receptors, neurokinin-1 - metabolism (436) 436
female (370) 370
mice (339) 339
substance p - pharmacology (317) 317
tachykinin nk1 receptor (312) 312
biochemistry & molecular biology (284) 284
substance p - metabolism (272) 272
nk1 (254) 254
dose-response relationship, drug (242) 242
receptor (234) 234
piperidines - pharmacology (226) 226
rats, sprague-dawley (225) 225
tachykinins (225) 225
neurokinin-1 receptor (224) 224
neurokinin (208) 208
rat (206) 206
neurons (191) 191
rats, wistar (189) 189
neurokinin nk1 receptors (185) 185
tachykinin (180) 180
nk1 receptors (175) 175
receptors (167) 167
guinea pigs (166) 166
nk1 receptor antagonist (162) 162
antagonist (161) 161
inflammation (159) 159
neuropeptides (156) 156
substance-p receptor (152) 152
receptors, neurokinin-1 - physiology (151) 151
tachykinin receptors (145) 145
substance p - analogs & derivatives (144) 144
gene-related peptide (141) 141
immunohistochemistry (141) 141
adult (140) 140
pain (140) 140
physiology (138) 138
expression (132) 132
receptor antagonist (132) 132
aprepitant (129) 129
chemistry, medicinal (127) 127
potent (127) 127
vomiting - chemically induced (127) 127
brain (122) 122
central-nervous-system (122) 122
in vitro techniques (122) 122
binding-sites (118) 118
disease models, animal (118) 118
middle aged (118) 118
nausea (118) 118
nonpeptide antagonist (117) 117
receptors, neurokinin-1 - genetics (117) 117
oncology (114) 114
analysis (113) 113
chemistry, organic (113) 113
indoles - pharmacology (113) 113
chemotherapy (112) 112
cancer (110) 110
double-blind (109) 109
peptide fragments - pharmacology (109) 109
antagonists (108) 108
emesis (104) 104
activation (103) 103
clinical neurology (103) 103
mice, inbred c57bl (103) 103
spinal-cord (103) 103
vomiting (102) 102
capsaicin (101) 101
research (101) 101
in-vitro (99) 99
spinal cord (99) 99
substance p - antagonists & inhibitors (99) 99
time factors (99) 99
neurogenic inflammation (97) 97
tachykinin nk (97) 97
tachykinin nk1 (96) 96
antiemetics - therapeutic use (95) 95
immunology (95) 95
psychiatry (94) 94
nk-1 receptor (93) 93
substance p - physiology (91) 91
prevention (90) 90
receptors, neurokinin-2 - antagonists & inhibitors (88) 88
article (87) 87
behavior, animal - drug effects (87) 87
cisplatin-induced emesis (86) 86
vomiting - prevention & control (85) 85
depression (84) 84
peptides (84) 84
receptors, neurokinin-1 - agonists (84) 84
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2279) 2279
Japanese (31) 31
French (6) 6
German (6) 6
Russian (5) 5
Chinese (3) 3
Hungarian (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Pharmacological Sciences, ISSN 0165-6147, 2003, Volume 24, Issue 11, pp. 580 - 588
The health burden of stress-related diseases, including depression and anxiety disorders, is rapidly increasing, whereas the range of available... 
CORTICOTROPIN-RELEASING HORMONE | ARGININE-VASOPRESSIN | ANTAGONIST R121919 | Y NPY | IN-VIVO | PHARMACOLOGY & PHARMACY | P NK1 RECEPTOR | ALCOHOL-CONSUMPTION | DORSAL RAPHE NUCLEUS | SUBSTANCE-P | ANXIOLYTIC-LIKE ACTION | Receptors, Galanin - agonists | Receptors, Corticotropin-Releasing Hormone - metabolism | Humans | Receptors, Vasopressin - metabolism | Receptors, Corticotropin-Releasing Hormone - agonists | Receptors, Neuropeptide Y - metabolism | Depressive Disorder - drug therapy | Receptors, Neuropeptide - metabolism | Receptors, Neurokinin-1 - agonists | Receptors, Neuropeptide - agonists | Receptors, Neurokinin-1 - metabolism | Receptors, Neuropeptide Y - antagonists & inhibitors | Anxiety Disorders - metabolism | Anxiety Disorders - drug therapy | Receptors, Neuropeptide Y - agonists | Receptors, Galanin - antagonists & inhibitors | Neurokinin-1 Receptor Antagonists | Receptors, Vasopressin - agonists | Receptors, Neuropeptide - antagonists & inhibitors | Clinical Trials as Topic | Depressive Disorder - metabolism | Animals | Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors | Receptors, Galanin - metabolism | Antidiuretic Hormone Receptor Antagonists | Neuropeptide Y | Care and treatment | Pharmacology, Experimental | Depression, Mental | Clinical trials | Vasopressin | Prevention | Antidepressants | Analysis | Tachykinins | Physiological aspects | Causes of | Anxiety | Health aspects | drug development
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 02/2010, Volume 285, Issue 6, pp. 3973 - 3985
Journal Article
Current Opinion in Pharmacology, ISSN 1471-4892, 08/2017, Volume 35, pp. 94 - 100
Receptor distribution studies have played a key role in the characterization of receptor systems (e.g. GABA , NMDA (GluNRs), and Neurokinin 1) and in... 
TACHYKININ NK1 RECEPTOR | ANTAGONIST APREPITANT | NMDA-RECEPTORS | PHARMACOLOGY & PHARMACY | QUANTITATIVE AUTORADIOGRAPHY | NEUROKININ-1 RECEPTOR | RAT-BRAIN | SUBSTANCE-P | BINDING-SITES | GABA(B) RECEPTOR | GLYCINE-BINDING
Journal Article
Epilepsy Research, ISSN 0920-1211, 2011, Volume 97, Issue 1, pp. 183 - 189
Journal Article
The Journal of Cell Biology, ISSN 0021-9525, 12/2007, Volume 179, Issue 5, pp. 981 - 997
Although cell surface metalloendopeptidases degrade neuropeptides in the extracellular fluid to terminate signaling, the function of peptidases in endosomes is... 
Protein isoforms | Receptors | Endocytosis | Small interfering RNA | Antibodies | Cell membranes | Recycling | Endosomes | Vehicles | ENDOTHELIN-CONVERTING ENZYME | NEUTRAL ENDOPEPTIDASE | COUPLED RECEPTORS | NK1 RECEPTOR | SUBSTANCE-P | ENDOCYTOSIS | ACTIVITY-MODIFYING PROTEIN-1 | BRADYKININ | GROWTH-FACTOR-I | CATHEPSIN-B | CELL BIOLOGY | Hydrolysis - drug effects | Receptors, Calcitonin - metabolism | Humans | Metalloendopeptidases - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Protein Transport - drug effects | Calcitonin Receptor-Like Protein | Arrestins - metabolism | Endothelin-Converting Enzymes | Isoenzymes - metabolism | Hydrogen-Ion Concentration - drug effects | Protein Binding - drug effects | Endosomes - drug effects | Cell Membrane - metabolism | Membrane Proteins - metabolism | Calcitonin Gene-Related Peptide - metabolism | Cell Membrane - drug effects | Receptor Activity-Modifying Protein 1 | Metalloendopeptidases - antagonists & inhibitors | Bradykinin - metabolism | Angiotensin II - metabolism | Aspartic Acid Endopeptidases - antagonists & inhibitors | Endocytosis - drug effects | Enzyme Inhibitors - pharmacology | Rats | Angiotensin I - metabolism | Animals | Signal Transduction - drug effects | beta-Arrestins | Aspartic Acid Endopeptidases - metabolism | Receptor, Angiotensin, Type 1 - metabolism | Cell Line, Tumor | Receptor Activity-Modifying Proteins | Endosomes - enzymology | Life Sciences | Biomolecules | Subcellular Processes | Cellular Biology | Biochemistry, Molecular Biology
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2017, Volume 140, Issue 2, pp. 447 - 453.e3
Journal Article
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2012, Volume 22, Issue 8, pp. 562 - 568
Journal Article